Corporate GovernanceJun 29, 2026, 06:07 AM
Takeda Pharmaceutical Amends Articles of Incorporation
AI Summary
Takeda Pharmaceutical Company Limited has filed an amended version of its Articles of Incorporation, with the latest changes effective June 29, 2026. The updated articles outline the company's corporate name, head office location, and business purposes. Key provisions include the total authorized shares, unit share size, and the composition of the Board of Directors and Audit and Supervisory Committee.
Key Highlights
- Articles of Incorporation amended effective June 29, 2026.
- Total authorized shares set at 3,500,000,000.
- One unit of shares consists of 100 shares.
- Maximum of 12 Directors (excluding Audit and Supervisory Committee Members).
- Maximum of 4 Directors who are Audit and Supervisory Committee Members.
- Details on general meeting of shareholders procedures and voting rights.
Price Impact
More from TAK